Scottish health technology start-up Infix Support has secured a contract with health board NHS Lothian.
The company, founded by consultant anaesthetist Dr Matthew Freer in 2019, has developed cloud-based software infix: Schedule, which aims to improves the efficiency of surgical operating theatres while tackling patient waiting list backlogs, alongside virtual portal infix: Preop, to optimise the patient pathway.
The NHS Lothian contract follows a successful clinical trial with NHS Lanarkshire, where Infix increased operating theatre utilisation by 27%. A separate independent review by the University of Stirling found that infix: Schedule can improve theatre efficiency by up to 37%.
Chief executive Freer explained: “NHS Lothian has shown a visionary approach around the use of digital innovation to help tackle the challenge of lengthy waiting times for planned surgery.
“In a post pandemic world, it is a challenge that has never been more critical with a backlog of people waiting for much needed surgery.”
Calum Campbell, chief executive at NHS Lothian, said: “We know that waiting longer for surgery can cause distress and deteriorating health for patients.
“That’s why we are keen to embrace innovation that helps reduce waiting times by optimising the efficient use of our theatres - the use of the Infix scheduling tool enables us to do exactly that.”
Infix recently secured a seven-figure investment from a group of UK and International business leaders and entrepreneurs, while John Waddell, the former Archangels chief executive and experienced non-executive director, was appointed as chair earlier this year.
Angela Brown joined the team as chief financial officer, while Forrit founder Peter Proud is also on the company’s board.
Infix plans to continue developing its product range over the coming months, while adding to its team and extending its reach across the UK and internationally.
The Glasgow-based business also has a number of further contracts in the pipeline, which it expects to announce during the first half of 2023.
Don't miss the latest headlines with our twice-daily newsletter - sign up here for free.
